Expression of tenascin in normal and diseased human kidneys

Japanese Journal of Nephrology

Volumn 38, Issue 5, 1996, Pages 213-219

  Okada, Mitsuru ^a   Takemura, Tsukasa ^a   Murakami, Katsumi ^a   Hino, Satoshi ^a   Yoshioka, Kazuo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glomerulonephritis; Tenascin

Indexed keywords

MESSENGER RNA; TENASCIN;

ADULT; ARTICLE; GENETICS; GLOMERULONEPHRITIS; HUMAN; KIDNEY; METABOLISM;

ADULT; GLOMERULONEPHRITIS; HUMANS; KIDNEY; RNA, MESSENGER; TENASCIN;

EID: 0030144407     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T: Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131-139, 1986
2. Chiquet-Ehrismann R: What distinguishes tenascin from fibronectin? FASEB J 4: 2598-2604, 1990
3. Erickson HP, Bourdon MA: Tenascin: An extracellular matrix protein prominent in specialized embryonic tissue and tumors. Annu Rev Cell Biol 5: 71-92, 1989
4. Chiquet M: Tenascin: An extracellular matrix protein involved in morphogenesis of epithelial organs Kidney Int 41: 629-631, 1992
5. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I: Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implications. Hum Pathol 22: 636-643, 1991
6. Spring J, Beck K, Chiquet-Ehrismann R: Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 59: 325-334, 1989
7. Striker LMM, Killen PD, Chi E, Striker GE: The composition of glomerulosclerosis. 1. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 51: 181-192, 1984
8. Yoshioka K, Takemura T, Matsubara T, Miyamoto H, Akano N, Maki S: Immunohistochemical studies of reflux nephropathy: The role of extracellular matrix, membrane attack complex, and immune cells in glomerular sclerosis. Am J Pathol 129: 223-231, 1987
9. Oomura A, Nakamura T, Arakawa M, Ooshima A, Isemura M: Alternations in extracellular matrix components in human glomerular diseases. Virchows Arch [A] 415: 151-159, 1989
10. Yoshioka K, Tohda M, Takemura T, Matsubara K, Akano N, Ooshima A, Maki S: Distribution of type 1 collagen in human kidney diseases in comparison with type III collagen. J Pathol 162: 141-148, 1990
11. Assad L, Schwartz MM, Virtanen I, Gould VE: Immunotocalization of tenascin and cellular fibronectins in diverse glomerulonepathies. Virchows Arch [B] 63: 307-316, 1993
12. Truong LD, Pindur J, Barrios R, D'Agati V, Lechago J, Suki W, Majesky M. Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions. Kidney Int 45: 201-210, 1994
13. Yoshioka K, Takemura T, Murakami K, Okada M, Yagi K, Miyazato H, Matsumoto K, Maki S: In situ expression cytokines in IgA nephritis Kidney Int 44: 825-833, 1993
14. Okada M, Yoshioka K, Takemura T, Akano N, Aya N, Murakami K, Maki S: Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor. Virchows Arch [A] 422: 367-373, 1993
15. Sin A, Carnemolla B, Saginati M, Lepnni A, Casari G, Baralle F, Zardi L: Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes, recognized by two monoclonal antibodies. Nucleic Acids Res 19: 525-531, 1991
16. Terenghi G, Polak JM: Use of comparative in situ hybridization and immunohistochemistry for the study of regulatory peptide. In: In Situ Hybridization: Medical Applications, ed by Coulton GR, de Bellcroche J, Boston, Kluwer Academic Publishers, pp 37-51, 1992
17. Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, Maki S: Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch [A] 424: 459-464, 1994
18. Ekblom P, Weller A: Ontogeny of tubulointerstitial cells. Kidney Int 39: 394-400, 1991
19. Sappino AP, Schürch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63: 144-161, 1990
20. Vangelista A, Fransca GM, Severi B, Bonomini V The role of myofibroblasts in renal interstitial fibrosis and their relationship with fibronectin and type IV collagen. Contrib Nephrol 70: 135-141, 1989
21. Truong LD. Majesky M, Pindur J: Tenascin is synthesized and secreted by rat mesangial cells in culture and is present in extra-cellular matrix in human glomerular diseases. J Am Soc Nephrol 4: 1171-1777, 1994
22. Yamamoto T, Nakamura T, Noble NA, Ruoslahti ER, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
23. Yamaoto T, Nobel NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlines development of progressive kidney fibrosis. Kidney Int 45: 916-927, 1994
24. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyazato H, Maki S: Transforming growth factor-βprotein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68: 154-163, 1993
25. Mackie EJ, Halfter W, Liverani D: Induction of tenascin in healing wounds. J Cell Biol 107: 2757-2767, 1988